Articles from Biotech Business (July 1, 2006)

Title	Author	Type	Words
CEPTYR BEGINS IND-ENABLING STUDIES FOR TYPE II DIABETES.			533
FDA APPROVES COLLAGENEX'S ORACEAL FOR ROSACEA.			811
FDA COMMITTEE TO CONSIDER NAVY'S RESUS TRAUMA TRIAL.			443
MGI PHARMA UNVEILS DACOGEN (DECITABINE) FOR INJECTION.			779
VIOQUEST INITIATES CLINICAL TRIAL FOR AKT THERAPEUTIC.			384